Patrick Ryan: Page 6

Want to write for Entrepreneur too? Apply to join Entrepreneur Leadership network.

Latest: Page 6

Business News

TAL Education Vs. Yum China: Which Chinese Stock is a Better Buy?

With a new administration, investors can be less concerned with Chinese companies getting delisted from U.S. exchanges. This makes it a great time to consider stocks from China. Tal Education Group (TAL) and Yum China Holdings (YUMC) are two top companies in China, but which is a better now now? Read more to find out.

Business News

Zscaler vs. McAfee: Which Cybersecurity Stock is a Better Buy?

Zscaler (ZS) and McAfee (MCFE) are two cybersecurity stocks that investors should consider. In 2020, ZS was an outperformed, while MCFE has grabbed the baton this year. Which of these is the better buy?.

Business News

3 Stocks to Buy as the Video Game Industry Continues to Expand

The video game industry exploded during the COVID-19 pandemic. That growth isn't expected to slow anytime soon, with generations Y and Z hooked on games. Three gaming stocks that investors should keep an eye on are Nintendo (NTDOY), Playtika Holding (PLTK), and Gravity (GRVY). Read more to learn why.

Business News

Three Strong Buy Stocks to Add to Your Portfolio

The proprietary POWR Ratings system is calculated daily based on 118 factors. Stocks that rated a Strong Buy have proven to outperform the market, which is why investors should keep a close on on recent upgrades. Patrick Ryan highlights three recent Strong Buy upgrades: Foot Locker (FL), Kohl's Corporation (KSS), and Nathan's Famous (NATH).

Business News

Avoid These 3 Downgraded Stocks

The stock market's character has changed in 2021. For investors, it means they need to be even more selective and carefully assess their own holdings. Ashford Hospitality Trust (AHT), Ideal Power (IPWR), and Viad (VVI) are 3 downgraded stocks that investors should avoid.

Business News

Clover vs. Centene: Which Healthcare Plan Stock is a Better Buy?

Clover (CLOV) and Centene (CNC) are two companies that offer healthcare plans to customers. CLOV has been in the headlines due to its high-profile investors, while CNC is lesser-known. Patrick Ryan explains why CNC is the better buy.